For the year ending 2025-12-31, BBNX made $100,251K in revenue. -$72,862K in net income. Net profit margin of -72.68%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Net sales | 100,251 | 65,124 | ||
| Cost of sales | 44,714 | 29,236 | ||
| Gross profit | 55,537 | 35,888 | ||
| Research and development | 34,789 | 26,184 | ||
| Sales and marketing | 61,404 | 37,086 | ||
| General and administrative | 31,025 | 17,869 | ||
| Total operating expenses | 127,218 | 81,139 | ||
| Loss from operations | -71,681 | -45,251 | ||
| Interest income | 10,932 | 3,909 | ||
| Other expense | -1 | -2 | ||
| Change in fair value of warrant liabilities | 12,450 | 13,412 | ||
| Total other expense, net | -1,519 | -9,505 | ||
| Net loss | -73,200 | -54,756 | ||
| Unrealized gain (loss) on short-term and long-term investments | 338 | -72 | ||
| Comprehensive loss | -72,862 | -54,828 | ||
| Basic EPS | -1.81 | -8.6 | ||
| Diluted EPS | -1.81 | -8.6 | ||
| Basic Average Shares | 40,529,051 | 6,365,064 | ||
| Diluted Average Shares | 40,529,051 | 6,365,064 | ||
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)